Logo image of AMBC

AMBAC FINANCIAL GROUP INC (AMBC) Stock Fundamental Analysis

NYSE:AMBC - New York Stock Exchange, Inc. - US0231398845 - Common Stock - Currency: USD

7.99  +0.24 (+3.1%)

After market: 7.99 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AMBC. AMBC was compared to 143 industry peers in the Insurance industry. AMBC may be in some trouble as it scores bad on both profitability and health. AMBC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AMBC had positive earnings in the past year.
AMBC had a positive operating cash flow in the past year.
In multiple years AMBC reported negative net income over the last 5 years.
In multiple years AMBC reported negative operating cash flow during the last 5 years.
AMBC Yearly Net Income VS EBIT VS OCF VS FCFAMBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

The Return On Assets of AMBC (-6.24%) is worse than 92.31% of its industry peers.
The Return On Equity of AMBC (-58.73%) is worse than 93.01% of its industry peers.
Industry RankSector Rank
ROA -6.24%
ROE -58.73%
ROIC N/A
ROA(3y)0.15%
ROA(5y)-0.62%
ROE(3y)-5.38%
ROE(5y)-11.87%
ROIC(3y)N/A
ROIC(5y)N/A
AMBC Yearly ROA, ROE, ROICAMBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

AMBC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMBC Yearly Profit, Operating, Gross MarginsAMBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

3

2. Health

2.1 Basic Checks

AMBC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMBC has been increased compared to 1 year ago.
Compared to 5 years ago, AMBC has more shares outstanding
AMBC has a better debt/assets ratio than last year.
AMBC Yearly Shares OutstandingAMBC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AMBC Yearly Total Debt VS Total AssetsAMBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.17, we must say that AMBC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AMBC (0.17) is better than 69.93% of its industry peers.
AMBC has a debt to FCF ratio of 196.85. This is a negative value and a sign of low solvency as AMBC would need 196.85 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 196.85, AMBC is doing worse than 78.32% of the companies in the same industry.
AMBC has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
AMBC has a Debt to Equity ratio of 0.18. This is in the better half of the industry: AMBC outperforms 72.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 196.85
Altman-Z 0.17
ROIC/WACCN/A
WACC3.06%
AMBC Yearly LT Debt VS Equity VS FCFAMBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

AMBC has a Current Ratio of 0.25. This is a bad value and indicates that AMBC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.25, AMBC is in the better half of the industry, outperforming 70.63% of the companies in the same industry.
A Quick Ratio of 0.25 indicates that AMBC may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.25, AMBC is doing good in the industry, outperforming 70.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
AMBC Yearly Current Assets VS Current LiabilitesAMBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

The earnings per share for AMBC have decreased strongly by -79.90% in the last year.
The earnings per share for AMBC have been decreasing by -21.40% on average. This is quite bad
Looking at the last year, AMBC shows a very strong growth in Revenue. The Revenue has grown by 45.47%.
AMBC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.86% yearly.
EPS 1Y (TTM)-79.9%
EPS 3Y-13.99%
EPS 5Y-21.4%
EPS Q2Q%-137.5%
Revenue 1Y (TTM)45.47%
Revenue growth 3Y-4.34%
Revenue growth 5Y-14.86%
Sales Q2Q%-14.18%

3.2 Future

The Earnings Per Share is expected to decrease by -14.64% on average over the next years. This is quite bad
The Revenue is expected to decrease by -43.27% on average over the next years. This is quite bad
EPS Next Y-95.14%
EPS Next 2Y-14.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y-43.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMBC Yearly Revenue VS EstimatesAMBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 200M 400M 600M
AMBC Yearly EPS VS EstimatesAMBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20

1

4. Valuation

4.1 Price/Earnings Ratio

AMBC is valuated rather expensively with a Price/Earnings ratio of 19.02.
AMBC's Price/Earnings ratio is a bit more expensive when compared to the industry. AMBC is more expensive than 66.43% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.78. AMBC is valued slightly cheaper when compared to this.
AMBC is valuated quite expensively with a Price/Forward Earnings ratio of 391.67.
80.42% of the companies in the same industry are cheaper than AMBC, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, AMBC is valued quite expensively.
Industry RankSector Rank
PE 19.02
Fwd PE 391.67
AMBC Price Earnings VS Forward Price EarningsAMBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, AMBC is valued a bit more expensive than 77.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 535.71
EV/EBITDA N/A
AMBC Per share dataAMBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as AMBC's earnings are expected to decrease with -14.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.64%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMBC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMBAC FINANCIAL GROUP INC

NYSE:AMBC (4/25/2025, 8:04:00 PM)

After market: 7.99 0 (0%)

7.99

+0.24 (+3.1%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-12 2025-05-12/amc
Inst Owners87.7%
Inst Owner Change-0.52%
Ins Owners3.83%
Ins Owner Change2.53%
Market Cap408.21M
Analysts85
Price Target17.34 (117.02%)
Short Float %4.98%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)15.43%
Min Revenue beat(2)-16.44%
Max Revenue beat(2)47.29%
Revenue beat(4)3
Avg Revenue beat(4)26.29%
Min Revenue beat(4)-16.44%
Max Revenue beat(4)47.29%
Revenue beat(8)5
Avg Revenue beat(8)11.85%
Revenue beat(12)7
Avg Revenue beat(12)32.95%
Revenue beat(16)9
Avg Revenue beat(16)30.47%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.02
Fwd PE 391.67
P/S 1.08
P/FCF 535.71
P/OCF 535.71
P/B 0.48
P/tB 4.35
EV/EBITDA N/A
EPS(TTM)0.42
EY5.26%
EPS(NY)0.02
Fwd EY0.26%
FCF(TTM)0.01
FCFY0.19%
OCF(TTM)0.01
OCFY0.19%
SpS7.4
BVpS16.77
TBVpS1.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.24%
ROE -58.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 0.2%
ROA(3y)0.15%
ROA(5y)-0.62%
ROE(3y)-5.38%
ROE(5y)-11.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 196.85
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 0.17
F-Score4
WACC3.06%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.9%
EPS 3Y-13.99%
EPS 5Y-21.4%
EPS Q2Q%-137.5%
EPS Next Y-95.14%
EPS Next 2Y-14.64%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.47%
Revenue growth 3Y-4.34%
Revenue growth 5Y-14.86%
Sales Q2Q%-14.18%
Revenue Next YearN/A
Revenue Next 2Y-43.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-134.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-97.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.94%
OCF growth 3YN/A
OCF growth 5YN/A